Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson’s disease-Reference-Cited by-同舟云学术

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson’s disease

Published:2012-04-27 Issue:1 Volume:20 Page:50-56
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:

Author:

Schapira A. H. V.,Barone P.,Hauser R. A.,Mizuno Y.,Rascol O.,Busse M.,Debieuvre C.,Fraessdorf M.,Poewe W.,

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1331.2012.03712.x/fullpdf

Reference26 articles.

1. The movement disorder society evidence-based medicine review update: treatments for the motor symptoms of Parkinson’s disease;Fox;Mov Disord,2011

2. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology;Pahwa;Neurology,2006

3. Review of the therapeutic management of Parkinson’s disease: report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section: part I: early (uncomplicated) Parkinson’s disease;Horstink;Eur J Neurol,2006

4. Review of the therapeutic management of Parkinson’s disease: report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES): part II: late (complicated) Parkinson’s disease;Horstink;Eur J Neurol,2006

5. Treatment options in the modern management of Parkinson disease;Schapira;Arch Neurol,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial;Drug Design, Development and Therapy;2023-08

2. A pragmatic, personalised approach to treatment initiation in Parkinson's disease;The Lancet Neurology;2020-05

3. Factors to Consider in the Selection of Dopamine Agonists for Older Persons with Parkinson’s Disease;Drugs & Aging;2019-01-09

4. Efficacy and safety of pramipexole extended-release in Parkinson's disease: a review based on meta-analysis of randomized controlled trials;European Journal of Neurology;2017-05-08

5. Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson’s Disease;Parkinson's Disease;2017